Curium US Holdings LLC to acquire Lantheus Holdings, Inc.

Curium US Holdings LLC has agreed to acquire Lantheus Holdings, Inc. in a transaction designed to take the healthcare company private. The deal was announced on 3 August 2026. Both the buyer and the target are based in the United States. The specific financial value of the transaction has not been disclosed, and no details regarding the consideration type have been reported. As a going-private deal, this move will remove Lantheus from public markets, though the precise terms remain confidential. The sector is identified as healthcare, reflecting the target’s operational focus. No completion date has been set, and the transaction remains in review. The process is subject to standard regulatory approvals and other customary closing conditions. Stakeholders are awaiting further updates on the timeline for finalising the agreement. The absence of a reported deal value means that the scale of the acquisition cannot be determined from the available information. The parties have not provided additional context on the strategic rationale for the buyout. The current status indicates that the deal is still under examination by relevant authorities.